Brief: Astrazeneca Pharma India Says MD Gagandeep Singh Bedi Resigns
14/12/2022 13:57
Dec 14 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* MD GAGANDEEP SINGH BEDI RESIGNS
* SANJEEV PANCHAL NAMED MD
Source text for Eikon: ID:nBSE9F5dt7
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication